Nan Shan Life Insurance Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$69.8M |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$67M |
| 3 |
Medtronic
MDT
|
+$49M |
| 4 |
Microsoft
MSFT
|
+$44.8M |
| 5 |
Gilead Sciences
GILD
|
+$43.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$80.9M |
| 2 |
NVIDIA
NVDA
|
+$66.4M |
| 3 |
XYZ
Block Inc
XYZ
|
+$61.3M |
| 4 |
Tesla
TSLA
|
+$56.2M |
| 5 |
Valero Energy
VLO
|
+$48.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 8.96% |
| 4 | Financials | 8.7% |
| 5 | Communication Services | 8.25% |
Similar funds
Nan Shan Life Insurance's Q1 2022 Portfolio in Review
As of Q1 2022, Nan Shan Life Insurance held 106 positions worth $5.71B, down 13% from $6.59B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Nan Shan Life Insurance withdrew a net $305M in Q1 2022, closing 20 positions and reducing 26 holdings. Its most notable exit was AvalonBay Communities, an estimated $44.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Nan Shan Life Insurance opened a new position in Medtronic worth $51.4M.
- Nan Shan Life Insurance's largest Q1 2022 buy was Medtronic: 463,693 shares worth $51.4M.
- Nan Shan Life Insurance added most to Vanguard Long-Term Treasury ETF in Q1 2022, an estimated $69.8M increase.
- Nan Shan Life Insurance's biggest Q1 2022 reduction was Phillips 66, cutting an estimated $80.9M.
- Nan Shan Life Insurance fully exited AvalonBay Communities in Q1 2022, selling an estimated $44.4M.
- Nan Shan Life Insurance's ten largest holdings make up 40% of its $5.71B portfolio in Q1 2022.
- Nan Shan Life Insurance opened 7 new positions and closed 20 in Q1 2022.
- Nan Shan Life Insurance's portfolio value fell 13% quarter-over-quarter to $5.71B.
Based on Nan Shan Life Insurance's 13F filing for Q1 2022, filed 13 May 2022.